The Connection Between H. pylori Infection and Anemia

Infection with Helicobacter pylori, the spiral-shaped bacterium that colonizes the stomach lining of roughly half the world’s population, is an established contributor to anemia, particularly iron deficiency anemia. A large meta-analysis pooling dozens of observational studies found that people harboring the infection were about 72 percent more likely to have iron deficiency anemia than uninfected people.¹ The relationship goes beyond a statistical association: multiple biological mechanisms explain how the bacterium quietly depletes iron, and in some cases vitamin B12, over months or years. What makes this connection clinically important is that eradicating the infection can reverse the anemia even without iron supplements.

How Strong Is the Epidemiological Evidence?

The most comprehensive look at this question comes from a 2016 systematic review and meta-analysis that pooled data from studies across multiple countries and age groups. The analysis found that H. pylori-infected individuals had a pooled odds ratio of 1.72 for iron deficiency anemia compared to uninfected controls, based on 14 observational studies. For iron deficiency without frank anemia the odds ratio was 1.33 across 30 studies, and for anemia of any type it was 1.15 across 23 studies.¹ In plain terms, the infection raises the risk of being iron-deficient by a meaningful margin, with the strongest association showing up specifically in iron deficiency anemia rather than in low iron stores alone.

Those numbers represent averages across many different populations, so the real-world effect varies. In regions where H. pylori is extremely common and diets are already low in iron, the contribution of the infection to anemia rates is probably larger. In well-nourished populations with lower infection rates, other causes of anemia may overshadow it. Still, the consistency of the association across dozens of studies and populations, combined with biological plausibility, has been enough to earn H. pylori a place in international guidelines as something worth investigating when anemia has no other obvious explanation.

How H. pylori Depletes Iron

There is no single mechanism at work. The bacterium drains iron through at least four overlapping pathways, which is part of why the resulting anemia can be stubborn and hard to treat with supplements alone.

Chronic Low-Grade Bleeding

H. pylori infection inflames and damages the stomach lining, and in many people this produces small amounts of bleeding that are invisible to the naked eye. A study of Yupik communities in Alaska, where H. pylori prevalence was extremely high, found that among subjects with elevated fecal blood levels who underwent endoscopy, 97 percent had visibly abnormal stomachs with redness, thickening, hemorrhages, or erosions. Virtually all biopsies showed chronic active gastritis associated with H. pylori, and no other source of bleeding was found.² That kind of slow, invisible blood loss, sustained over months or years, gradually empties iron reserves.

Impaired Iron Absorption

Even when there is no significant bleeding, the infection can reduce the amount of iron you absorb from food. Research has directly demonstrated that H. pylori impairs iron uptake in infected individuals, contributing to iron depletion through a mechanism separate from blood loss.³ One reason this happens involves the stomach’s chemistry. Dietary iron, especially the non-heme iron found in grains and vegetables, needs an acidic environment and vitamin C (ascorbic acid) to be converted into a form the body can absorb. H. pylori gastritis raises intragastric pH (makes the stomach less acidic) and reduces ascorbic acid concentrations at the same time, creating a double hit to iron absorption.⁴

The Bacterium Competes for Iron Directly

H. pylori needs iron to survive and multiply, and it has evolved sophisticated systems to steal it from its human host. Researchers describe the competition for iron between host and pathogen as “the central battlefield” of the infection.⁵ One key weapon in the bacterium’s arsenal is a receptor for human lactoferrin, an iron-binding protein found in stomach secretions. Lactoferrin is present in significant amounts in inflamed stomach tissue, and H. pylori can strip iron from it to fuel its own growth.⁶ The bacterium also uses a high-affinity iron transporter called FeoB to scavenge iron from its immediate environment.⁷ In effect, every iron atom that the bacterium grabs for itself is one less available for your red blood cells.

Hepcidin and the Inflammatory Blockade

There is a more systemic mechanism as well. Hepcidin is a hormone produced mainly by the liver that acts as the master regulator of iron metabolism. When hepcidin levels rise, the body locks iron away in storage and blocks its absorption from the gut. Normally, hepcidin goes down when iron stores are low so that the body can replenish them. But chronic infection and inflammation drive hepcidin up regardless of iron status, essentially trapping iron where it cannot be used. A study of school-age children found that those with active H. pylori infection had significantly higher hepcidin levels than uninfected children, and that the inflammatory stimulus to produce hepcidin was stronger than the counter-signal from iron deficiency.⁸ Additional clinical evidence supports the idea that inflammation-driven hepcidin elevation plays a role in anemia associated with H. pylori.⁹

Interestingly, an animal study found a somewhat different pattern in mice infected with H. pylori: gastric and liver hepcidin expression was actually downregulated, and the mice still developed anemia and depleted iron stores.¹⁰ This suggests the hepcidin story may differ between species or depend on the strain involved, and that iron depletion through bleeding and malabsorption can proceed even when the inflammatory hepcidin pathway is not the dominant driver.

Beyond Iron: The Vitamin B12 Connection

Iron is not the only nutrient threatened by H. pylori. The infection can also interfere with vitamin B12 absorption, though this link is less well known. Chronic H. pylori gastritis damages the stomach lining and can lead to atrophic gastritis over time. The cells that produce intrinsic factor, a protein essential for absorbing B12 in the small intestine, are the same cells being damaged. When intrinsic factor drops, B12 absorption falls, and over months to years this can cause megaloblastic anemia, a distinct type of anemia characterized by abnormally large red blood cells rather than the small, pale red cells seen in iron deficiency.¹¹

In rare but serious cases, H. pylori can trigger autoimmune damage to the stomach through a process called molecular mimicry, where the immune system confuses stomach lining cells with bacterial proteins. This can progress to pernicious anemia, a condition in which the body can no longer absorb B12 at all. One documented case showed that this process led not only to severe B12 deficiency but also to neurological damage (subacute combined degeneration of the spinal cord), and that eradicating H. pylori reversed the underlying process and corrected the deficiency.¹² A multicenter study comparing patients with autoimmune gastritis to those with non-autoimmune H. pylori gastritis found that the autoimmune group had considerably lower B12 levels and a much higher rate of B12 deficiency (about 13 percent versus under 2 percent), alongside lower ferritin and more iron deficiency as well.¹³

The practical takeaway is that H. pylori can cause two mechanistically different types of anemia. A patient might have iron deficiency anemia, megaloblastic anemia from B12 depletion, or even both at the same time. When both deficiencies overlap, the blood count can look confusingly normal because the small cells from iron deficiency and the large cells from B12 deficiency average each other out, masking both problems.

Eradication Can Reverse the Anemia

One of the most persuasive pieces of evidence for a causal link, rather than just a statistical association, is that killing the bacterium often fixes the anemia. A landmark study of patients with unexplained iron deficiency anemia and asymptomatic H. pylori gastritis treated them with antibiotics and then stopped their iron supplements entirely. At six months, 75 percent had recovered from anemia, and at twelve months that figure reached about 92 percent. Ferritin levels, which reflect iron stores, climbed from very low values to roughly four times higher.¹⁴ The fact that anemia resolved without any iron supplementation strongly implicates the infection itself as the cause.

A similar pattern appears in children. After successful H. pylori eradication, iron normalized in about 60 percent of children who had been iron-deficient, again without iron supplementation.¹⁵ When eradication therapy is combined with oral iron supplements, the response is even faster and more complete than iron supplements alone. One trial showed that hemoglobin returned to normal by about eight weeks in patients who received both H. pylori treatment and iron, while the group receiving iron alone took longer and never quite reached the same levels during follow-up.¹⁶ A separate review confirmed that combining eradication therapy with iron is more effective than iron alone.¹⁷

This has an important practical implication: if you have iron deficiency anemia that does not respond well to iron pills, or that keeps coming back after you stop taking them, an underlying H. pylori infection could be the reason the supplements are not working. The infection impairs absorption and creates ongoing losses, so simply adding more iron into a broken system often fails to solve the problem permanently.

Children, Adolescents, and Pregnant Women

Certain groups are disproportionately affected by the overlap of H. pylori and anemia. Children and adolescents in regions with high H. pylori prevalence are a major concern because they are still growing and their iron demands are already high. Multiple epidemiological studies and meta-analyses show that persistent H. pylori infection can lead to iron deficiency or iron deficiency anemia in these younger populations, and the infection is closely linked to cases that are recurrent or fail to respond to iron supplements.¹⁸ Pediatric guidelines now recommend considering H. pylori testing for children whose iron deficiency anemia keeps coming back or does not improve with standard treatment and no other cause has been found.

Pregnant women represent another vulnerable group. Pregnancy already increases iron demands dramatically, and H. pylori can compound the problem. A meta-analysis focused on pregnant women found a strikingly strong association between H. pylori infection and iron deficiency anemia during pregnancy, with an odds ratio of about 16.¹⁹ A study comparing infected and uninfected mothers found that those with H. pylori had lower hemoglobin levels at the start of pregnancy and experienced a more unfavorable drop in hemoglobin as pregnancy progressed.²⁰ Since maternal anemia during pregnancy carries risks for both mother and baby, identifying an underlying H. pylori infection could be meaningful in prenatal care, particularly in areas where the infection is common.

When Should Doctors Test for H. pylori in Anemia Workups?

International guidelines, including the widely cited Maastricht consensus, recommend testing for and treating H. pylori in patients with unexplained iron deficiency anemia. The logic is straightforward: if standard causes like heavy menstrual bleeding, colon polyps, or dietary insufficiency have been ruled out, H. pylori is a plausible culprit worth investigating. In practice, though, the recommendation is not universally applied. In countries where H. pylori prevalence is low, routine testing of every anemia patient could mean a lot of unnecessary testing and treatment. More importantly, in older patients, fixating on H. pylori could delay the diagnosis of more serious conditions, such as gastrointestinal cancers, that also cause iron deficiency anemia.²¹

The practical middle ground, which most gastroenterologists follow, is to consider H. pylori testing when iron deficiency anemia is truly unexplained after a thorough workup, or when it keeps recurring or resists oral iron therapy. Testing is especially worth considering in younger patients and in populations where H. pylori is common. For older adults, ruling out malignancy and other structural causes first remains the priority.

Strain Differences and Why Some Infections May Be Worse

Not every H. pylori infection causes the same degree of trouble. The bacterium comes in many strains, and some carry virulence factors that appear to worsen the impact on iron status. Research in children and adolescents with iron deficiency anemia has found that certain bacterial genes, particularly the sabA gene (which helps the bacterium adhere to inflamed stomach tissue), are associated with the development of iron deficiency anemia. The same study looked at VacA, a toxin produced by H. pylori: strains from children with anemia showed detectable VacA protein secretion, though gene expression levels were not consistently different from controls.²² This is an area where the science is still evolving, but the general direction suggests that strain-level differences help explain why some infected people develop anemia while others carry the bacterium for decades without any impact on their blood counts.

A Bacterium That Has Been With Us for Tens of Thousands of Years

H. pylori is not a recent invader. Genetic evidence shows that humans have been colonized by this bacterium for at least 50,000 years, likely throughout our evolution as a species.²³ The infection is typically acquired in childhood and, without treatment, persists for life. This long shared history means the bacterium has had ample time to refine its iron-scavenging tools, and the human body has evolved countermeasures to restrict iron access. The arms race between host and pathogen over iron is ancient and ongoing.

This evolutionary context also raises questions about the declining prevalence of H. pylori in industrialized nations. In many wealthy countries, infection rates have dropped sharply due to improved sanitation and widespread antibiotic use. That decline tracks with a drop in certain diseases like peptic ulcers and stomach cancer, but some researchers have speculated about unintended consequences of losing an organism we co-evolved with. For the topic of anemia, the implication is more concrete: as H. pylori becomes less common, its contribution to unexplained anemia shrinks proportionally, making it a lower-yield diagnostic target in low-prevalence settings but still an important one globally.